
Topic
Payer Policy
Medicare, commercial payer, PBM, and formulary-policy moves that shape launch curves and gross-to-net.

Pricing & Access· May 16, 2026 · 8 min read

Pricing & Access· May 16, 2026 · 10 min read
Wegovy vs Zepbound: label, access, and payer coverage compared
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 15, 2026 · 8 min read
Mounjaro coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 15, 2026 · 9 min read
Ozempic vs Mounjaro: label, access, and payer coverage compared
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 15, 2026 · 9 min read
Zepbound coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 14, 2026 · 8 min read
Ozempic coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 14, 2026 · 8 min read
Ozempic vs Wegovy: label, access, and payer coverage compared
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 14, 2026 · 8 min read
Wegovy coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 11, 2026 · 4 min read
IRA negotiation after the headline price: what access teams should watch

Pipeline· May 7, 2026 · 4 min read